Pay in 4 interest-free payments of $6.29 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
No significant adverse effects were reported in both the placebo and intervention groups (Table 3)
Patients choosing between oral and injectable options deserve clear, honest information about what theyre selecting
Forte A, Baldessarini RJ, Tondo L, Vzquez GH, Pompili M, Girardi P
The development of ChaC1 modulators introduces innovative approaches to cancer treatment
Avoid using this drug in patients with a personal or family history of MTC or patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
US$ 27.43
US$ 22.54
US$ 28.40
US$ 27.11
US$ 26.49
US$ 21.08
US$ 27.30
